A droopy eyelid – medically known as ptosis – is caused by weakening or stretching of the levator muscle that lifts the upper eyelid, and it can result from aging, genetics, nerve damage, injury, or underlying medical conditions. While many people associate droopy eyelids with getting older, the truth is that this condition can affect anyone at any age, and understanding the root cause is the first step toward finding the right solution.
If you’ve noticed one or both of your upper eyelids sitting lower than they used to, you’re not alone. Droopy eyelids are a common concern. Below, we’ll break down the specific causes, when to seek professional help, and what treatment options are available.
Tirzepatide is a breakthrough FDA-approved injectable medication that is changing the landscape of medical weight management. It functions as a dual-action GIP and GLP-1 receptor agonist, working on two different pathways to regulate blood sugar, reduce appetite, and slow digestion.
This dual mechanism leads to patients feeling full sooner and for longer periods, naturally decreasing calorie intake. The medication works by slowing gastric emptying, reducing appetite, and improving insulin sensitivity for sustained weight loss.
Determining who is a good candidate for tirzepatide involves evaluating a person’s health profile, goals, and commitment. The following characteristics describe ideal candidates:
Adults with a BMI of 30 or higher (classified as obese)
Adults with a BMI of 27-29.9 who have at least one weight-related condition
Type 2 diabetes or prediabetes
High blood pressure
High cholesterol
Sleep apnea
Osteoarthritis related to excess weight
Many successful patients have tried various diets and fitness regimens with limited or temporary success. If you’ve consistently put in effort but haven’t seen results, tirzepatide can provide the metabolic support to break through plateaus.
The most successful patients view tirzepatide as a partner in their wellness journey, not a magic bullet. Ideal candidates are motivated to:
Adopt and maintain healthier eating habits
Incorporate regular physical activity
Participate in ongoing medical monitoring
Commit to our comprehensive concierge program
A key differentiator of the ellevateMD program is direct physician oversight by our doctor. This ensures your treatment is tailored to you and adjusted as needed for optimal results and well-being.
Safety is our foremost priority. While tirzepatide is effective for many, certain medical conditions may prevent eligibility:
Personal or family history of Medullary Thyroid Carcinoma (MTC)
Family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
History of pancreatitis
Severe gastrointestinal issues, such as gastroparesis
Pregnancy, breastfeeding, or planning to become pregnant
Known serious allergy to tirzepatide or its ingredients
Tirzepatide is currently approved for adults 18 years and older. Our medical team carefully evaluates each patient’s overall health status within the approved range.
Patients taking certain medications, including insulin, sulfonylureas, or other blood sugar medications, may need careful evaluation.
The world of weight loss medication has expanded significantly. Tirzepatide stands out as the first medication to target two distinct receptors: GLP-1 and GIP. Alternative options include:
While both are GLP-1 receptor agonists, tirzepatide’s dual-action mechanism often produces more significant results. Clinical studies show that patients on tirzepatide typically lose 15-20% of body weight, compared to 10-15% with semaglutide.
Older medications like phentermine or orlistat work through different mechanisms and typically produce less dramatic results. Tirzepatide’s hormone-based approach addresses the root causes of appetite regulation rather than simply suppressing hunger temporarily.
The only definitive way to know who is a good candidate for tirzepatide is through professional medical consultation.
During consultation, we establish:
Expected weight loss timeline (typically 1 pound per week)
Realistic and achievable health milestones
Long-term maintenance planning
Integration with other aesthetic treatments to address skin changes
Tirzepatide offers a promising solution for individuals who have struggled with conventional weight loss methods. Ideal candidates have a BMI of 27 or higher, are committed to comprehensive lifestyle changes, and value the safety of an MD-monitored program. Due to specific medical contraindications, not everyone is eligible. The essential first step is a thorough consultation with Dr. Ann Jayaram to review your health history and confirm if this innovative treatment aligns with your wellness goals.
